CITIGROUP INC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 84 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2021$0
-100.0%
1
-99.9%
0.00%
Q1 2021$5,000
-64.3%
1,194
-67.0%
0.00%
Q4 2020$14,000
+250.0%
3,622
+274.9%
0.00%
Q3 2020$4,000
-63.6%
966
-62.3%
0.00%
Q2 2020$11,000
-56.0%
2,559
-56.2%
0.00%
Q1 2020$25,000
+56.2%
5,845
+40.8%
0.00%
Q4 2019$16,000
-66.0%
4,151
-22.8%
0.00%
Q3 2019$47,000
-23.0%
5,377
-17.4%
0.00%
Q2 2019$61,000
+60.5%
6,508
+12.3%
0.00%
Q1 2019$38,000
-97.3%
5,796
-96.2%
0.00%
-100.0%
Q4 2018$1,429,000
+0.7%
151,557
+115.0%
0.00%0.0%
Q3 2018$1,419,000
+13.6%
70,478
+64.6%
0.00%0.0%
Q2 2018$1,249,000
-11.5%
42,812
-9.7%
0.00%0.0%
Q1 2018$1,411,000
+134.0%
47,406
+153.1%
0.00%
Q4 2017$603,000
-87.4%
18,730
-86.4%
0.00%
-100.0%
Q3 2017$4,774,000
+263.6%
137,247
+211.4%
0.00%
+200.0%
Q2 2017$1,313,000
+1830.9%
44,077
+1827.3%
0.00%
Q1 2017$68,000
-1.4%
2,287
-41.5%
0.00%
Q4 2016$69,000
+475.0%
3,912
+698.4%
0.00%
Q3 2016$12,000
+50.0%
4900.0%0.00%
Q2 2016$8,000
-96.8%
490
-95.9%
0.00%
Q1 2016$248,000
+386.3%
11,852
+526.8%
0.00%
Q4 2015$51,000
+264.3%
1,891
+284.3%
0.00%
Q3 2015$14,000
+180.0%
492
+133.2%
0.00%
Q2 2015$5,000211
+1072.2%
0.00%
Q1 2015$0
-100.0%
18
-99.8%
0.00%
Q2 2014$103,000
-14.9%
11,2250.0%0.00%
Q1 2014$121,00011,2250.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2017
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders